Collaborate / Carl Steinbeisser

From proposals to the sustainability of results, our mission is to reduce the burden for researchers and empower them to collaborate efficiently.

[Collaborate / Carl Steinbeisser @EUcollaborate]

For this project on virtual twins we have helped writing the proposal back in early 2023. Max 6 of 65 submitted proposals have been selected for funding. This project made it.

[Fraunhofer IZI @FraunhoferIZI]

#FraunhoferIZI launches #CERTAINTY with partners, pioneering #VirtualTwin for personalised cancer care. Focused on multiple myeloma, backed by €10M EU, this collaboration is set to transform CAR-T therapy & precision medicine.

👉 https://t.co/qncSqv4Vtu

#InnovativeOncology

[Hypermarker @hypermarker]

A snapshot from our Annual Hypermarker Meeting in Valencia. Big thanks to @incliva_iis for their hospitality!
#Hypermarker #AnnualMeeting #Valencia #Incliva

[EAU Patient Information @EauPatient]

November is prostate cancer awareness month.

Prostate cancer is more common than you may think, it is the most frequent cancer among males. This November take some time to learn and spread awareness about this all too common disease.

[Dr. Animesh Acharjee @DrAnimeshAchar1]

#hiring ! 🎓 Our #PhDFellowship is pushing the boundaries of healthcare with cutting-edge AI and multiomics integration for hypertension treatment by patient's unique metabolomic profile. 🧬💊 Join us ! #AIHealthcare #HypertensionResearch #PersonalizedMedicine #Innovation

[Collaborate / Carl Steinbeisser @EUcollaborate]

At our last PIONEER meeting, we showcased the outcomes of our three groundbreaking studyathons. These events brought together diverse experts, conducting data analysis across multiple international datasets.

One paper is already published. More to come!

[Prostate PIONEER @ProstatePioneer]

Now at #ProstatePIONEER_GA23: B. De Meulder and R.Snijder chair the lessons learnt session from #PIONEER's 3️⃣ Studythons🙌
Questions adressed: long-term outcomes of patients on conserv. management, best treatment options and #AEs of systemic treatment in patients with mHSPCa .🩺

[Prostate PIONEER @ProstatePioneer]

Now at #ProstatePIONEER_GA23: B. De Meulder and R.Snijder chair the lessons learnt session from #PIONEER's 3️⃣ Studythons🙌
Questions adressed: long-term outcomes of patients on conserv. management, best treatment options and #AEs of systemic treatment in patients with mHSPCa .🩺

[Prostate PIONEER @ProstatePioneer]

A truly successfull meeting! 🤩 The final #ProstatePIONEER_GA23 has been officially closed by @NDowJames Project Coordinator and @Sevans_axelsson @EFPIA Project Lead 🎗️

We would like to thank everyone who contributed to this successful #GAM 🙏💙

[Prostate PIONEER @ProstatePioneer]

The 3rd #PIONEERStudyAThon23 was a great success! Main achievements: stable analytic platform set up (SAS Viya integrated & tested), study protocol refined, 2 R packages developed, new data sets identified on which study packages can be run, ideas for papers! Congratulations! 👏

[Prostate PIONEER @ProstatePioneer]

Day 2 of #PIONEERStudyAThon_23 successfully came to an end! Results: 5 target cohorts and 21 wrapper #AdverseEvents cohorts were defined in ATLAS! 👏 The study protocol has been refined and will be presented next day. Congratulations! Keep it up! 👏

[Collaborate / Carl Steinbeisser @EUcollaborate]

We are incredibly proud to have consulted and co-written this research proposal for the funding programme HorizonEurope. It was positively evaluated, with a remarkable review of 15 out of 15 points. The project just started, so stay tuned for more news to come!

[Hypermarker @hypermarker]

Hypermarker a #HorizonEurope project will unleash the potential of #pharmacometabolomics to develop and test new solutions for 'smart' prescriptions for #hypertension🩸💊
The proposal received a 10 million grant from #HorizonEurope and #UKResearchandInnovation & just started!

[PREFER: patient preferences @IMI_PREFER]

Interested in results from our clinical patient preference study on Multiple #Myeloma? #PREFERlegacy

https://t.co/xJtzHLSBq6

[Folkert Asselbergs @fwasselbergs]

CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research https://t.co/54JemEcxbK

[BigData@Heart @BigDataHeart]

Webinar invitation:
“Improving clinical research with routine health records – BigData@Heart” with Dipak Kotecha and Folkert Asselbergs.

11 January 2023, 11.30-12.30 CET

register here ->https://t.co/3S5mkzfYn8

[Health Data Science @HdsErasmusMC]

Interested in how we have been driving Study-a-Thons as a new paradigm to generate evidence with a dedicated highly focussed group of data partners, domain experts, data scientists, statistician, experts on guidelines?

https://t.co/8vbjj3xCKl

[PREFER: patient preferences @IMI_PREFER]

Want the full story behind the PREFER recommendations? Many of our reports on #PatientPreference methodology are available in full 👇

https://t.co/iFnkkBj2rM

#PREFERCaseStudies #PREFERLeagacy

[Collaborate / Carl Steinbeisser @EUcollaborate]

It's amazing the things that get accomplished when you lock a lot of data scientists, researchers, clinicians etc in a room for a week. From the 2 study-a-thons we helped organising we can tell it's fun. More in this recent publication
@OHDSI
@IMI_EHDEN
https://t.co/U8pTYXLPLh

[Juan Gómez Rivas @JGomezRivas]

The best way to start #movember 1) trim your mustache 2) join an initiative to improve men health quality such as @ProstatePioneer #PIONEER_StudyAThon_22 RWD on mHSPC to predict outcomes in order to improve healthcare quality #prostatecancer @NDowJames @Sevans_axelsson @Uroweb

[Collaborate / Carl Steinbeisser @EUcollaborate]

@ESC_Journals @ehj_ed @rladeiraslopes EQUATOR has now appraised our checklist and added CODE-EHR to their reporting database.

https://t.co/48fkDtlUZy

[Collaborate / Carl Steinbeisser @EUcollaborate]

EQUATOR has now appraised our checklist and added CODE-EHR to their reporting database.

https://t.co/48fkDtmsP6

[European Society of Cardiology Journals @ESC_Journals]

Must read: CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research https://t.co/aJhNQez32c

#EHJ #ESCCongress #ESCYoung @ehj_ed @rladeiraslopes

[PREFER: patient preferences @IMI_PREFER]

PREFER has issued recommendations on why, when and how to assess and use patient preferences in medical product decision-making.

Need a summary of the take-home messages? #PREFERlegacy 👇

https://t.co/44oJWS1lVg